These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29374802)

  • 1. Use of an ACE inhibitor or angiotensin receptor blocker is a major risk factor for dehydration requiring readmission in the setting of a new ileostomy.
    Charak G; Kuritzkes BA; Al-Mazrou A; Suradkar K; Valizadeh N; Lee-Kong SA; Feingold DL; Pappou EP
    Int J Colorectal Dis; 2018 Mar; 33(3):311-316. PubMed ID: 29374802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative use of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diuretics increases the risk of dehydration after ileostomy formation: population-based cohort study.
    de la Motte L; Nordenvall C; Martling A; Buchli C
    BJS Open; 2024 May; 8(3):. PubMed ID: 38818959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydration is the most common indication for readmission after diverting ileostomy creation.
    Messaris E; Sehgal R; Deiling S; Koltun WA; Stewart D; McKenna K; Poritz LS
    Dis Colon Rectum; 2012 Feb; 55(2):175-80. PubMed ID: 22228161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with hospital readmission following diverting ileostomy creation.
    Li W; Stocchi L; Cherla D; Liu G; Agostinelli A; Delaney CP; Steele SR; Gorgun E
    Tech Coloproctol; 2017 Aug; 21(8):641-648. PubMed ID: 28819783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Readmission for dehydration or renal failure after ileostomy creation.
    Paquette IM; Solan P; Rafferty JF; Ferguson MA; Davis BR
    Dis Colon Rectum; 2013 Aug; 56(8):974-9. PubMed ID: 23838866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Readmissions With Dehydration After Ileostomy Creation: Rethinking Risk Factors.
    Justiniano CF; Temple LK; Swanger AA; Xu Z; Speranza JR; Cellini C; Salloum RM; Fleming FJ
    Dis Colon Rectum; 2018 Nov; 61(11):1297-1305. PubMed ID: 30239391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
    Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A
    Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments.
    Hirai T; Yamaga R; Fujita A; Itoh T
    J Clin Pharm Ther; 2018 Dec; 43(6):829-835. PubMed ID: 29908131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we better predict readmission for dehydration following creation of a diverting loop ileostomy: development and validation of a prediction model and web-based risk calculator.
    Alqahtani M; Garfinkle R; Zhao K; Vasilevsky CA; Morin N; Ghitulescu G; Faria J; Boutros M
    Surg Endosc; 2020 Jul; 34(7):3118-3125. PubMed ID: 31451920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France.
    Oussalah A; Gleye S; Clerc Urmes I; Laugel E; Callet J; Barbé F; Orlowski S; Malaplate C; Aimone-Gastin I; Caillierez BM; Merten M; Jeannesson E; Kormann R; Olivier JL; Rodriguez-Guéant RM; Namour F; Bevilacqua S; Losser MR; Levy B; Kimmoun A; Gibot S; Thilly N; Frimat L; Schvoerer E; Guéant JL
    Clin Infect Dis; 2020 Dec; 71(9):2447-2456. PubMed ID: 32623470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy.
    Steely AM; Callas PW; Bertges DJ;
    J Vasc Surg; 2016 Mar; 63(3):715-21. PubMed ID: 26603543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverting ileostomy itself may not increase the rate of postoperative readmission related to dehydration after low anterior resection.
    Park SS; Kim MJ; Lee DE; Park SC; Han KS; Hong CW; Sohn DK; Chang HJ; Oh JH
    Ann Surg Treat Res; 2021 Aug; 101(2):111-119. PubMed ID: 34386460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin axis blockade, acute kidney injury, and perioperative morbidity in patients undergoing colorectal surgery: A retrospective cohort study.
    Bonavia A; Javaherian M; Skojec AJ; Chinchilli VM; Mets B; Karamchandani K
    Medicine (Baltimore); 2019 Aug; 98(33):e16872. PubMed ID: 31415426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.
    Maione A; Navaneethan SD; Graziano G; Mitchell R; Johnson D; Mann JF; Gao P; Craig JC; Tognoni G; Perkovic V; Nicolucci A; De Cosmo S; Sasso A; Lamacchia O; Cignarelli M; Manfreda VM; Gentile G; Strippoli GF
    Nephrol Dial Transplant; 2011 Sep; 26(9):2827-47. PubMed ID: 21372254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers on the day of surgery on myocardial injury after non-cardiac surgery: A retrospective cohort study.
    Kim J; Lee S; Choi J; Ryu DK; Woo S; Park M
    J Clin Anesth; 2024 Jun; 94():111401. PubMed ID: 38330844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the Risk of Readmission From Dehydration After Ileostomy Formation: The Dehydration Readmission After Ileostomy Prediction Score.
    Chen SY; Stem M; Cerullo M; Canner JK; Gearhart SL; Safar B; Fang SH; Efron JE
    Dis Colon Rectum; 2018 Dec; 61(12):1410-1417. PubMed ID: 30303886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin receptor blocker at discharge in patients with heart failure with reduced ejection fraction: Korean Acute Heart Failure (KorAHF) registry.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
    Int J Cardiol; 2018 Apr; 257():168-176. PubMed ID: 29506690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.